Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06658002

Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

Led by University of California, San Francisco · Updated on 2025-10-06

150

Participants Needed

2

Research Sites

104 weeks

Total Duration

On this page

Sponsors

U

University of California, San Francisco

Lead Sponsor

A

Aravind Eye Hospitals, India

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if adjunctive topical Cyclosporine A eye drops combined with standard of care topical Natamycin treatment improves vision outcomes in patients with fungal keratitis.

CONDITIONS

Official Title

Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with fungal keratitis confirmed by smear or culture, any ulcer length
  • Visual acuity between 20/40 (6/12) and 20/400 (3/60) at presentation
  • Age 18 years or older
  • Willing to participate in the study
Not Eligible

You will not qualify if you...

  • Co-infection with bacterial or viral keratitis
  • Corneal perforation
  • Need for therapeutic keratoplasty due to fungal keratitis
  • Unwilling or unable to follow up (e.g., living too far from hospital)
  • Presenting visual acuity better than 20/40 or worse than 20/400
  • Taking cyclosporine at any concentration on presentation
  • Visual acuity worse than 20/200 in the unaffected eye
  • Pregnancy
  • History of penetrating keratoplasty
  • Using topical steroids within 0-7 days before presentation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of California, San Farncisco

San Francisco, California, United States, 94143

Not Yet Recruiting

2

Aravind Eye Institute

Pondicherry, Tamil Nadu, India, 605 007

Actively Recruiting

Loading map...

Research Team

G

Gerami D Seitzman, MD

CONTACT

T

Thomas Lietman, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here